Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2

2(50.0%)

Phase 1

1(25.0%)

N/A

1(25.0%)

4Total

Phase 2(2)

Phase 1(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02264665Completed

OPALINE : A Study Of Morbidity And Mortality At 2 Years

Role: collaborator

NCT04462640Completed

Management of Infant Digestive Disorders and Quality of Life

Role: collaborator

NCT02301754Phase 1Completed

INVAC-1 Anti-Cancer hTERT DNA Immunotherapy

Role: collaborator

NCT03475199Not ApplicableUnknown

Evaluation of Personalised Support Program Effectiveness in Sperm Quality Improvement

Role: collaborator

NCT03075774Unknown

Observational Study About the Use of Fibrinogen in Adult Cardiac Surgery

Role: collaborator

NCT02957760Phase 2Unknown

Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.

Role: collaborator

NCT01089608Phase 2Completed

Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis

Role: collaborator

All 7 trials loaded